Efect of sitagliptin on excretion of protein in diabetic

The evaluation of sitagliptin on proteinuria in diabetic patient with nephropathy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017022532769N1

Enrollment

Registered

2017-06-13

Start date

2016-08-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabet type 2. E11.2 Non-insulin-dependent diabetes mellitus with renal complications

Interventions

Sitagliptin 25mg daily oral for 3 month.

Treatment - Drugs

Sitagliptin 25mg daily oral for 3 month

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Type 2 of diabet ; glomerular filtration rate more than 30 ; HbA1C 6.5-8.5 ; continue of previous diet , exersize & drug ; proteinuria more than 150mg/dl. Exclusion criteria: Patient do not allow continue of study ; drug adverse reaction ; blood suger more than difined range ; exacerbation of renal failure.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urine protein. Timepoint: 3 mo.before , before & 3 mo. after trial. Method of measurement: 24h urine protein /mg/dl.	—

Secondary

Measure	Time frame
Hypoglycemia. Timepoint: 3 month. Method of measurement: FBS check.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Ali Ahmadloo

Arak University of Medical Sciences

drahmadloo@irimc.org ,ma.ahmadloo@arakmu.ac.ir ,nassersaidi@yahoo.com ,afsanehtalaeii@yahoo.co+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026